Publications

Long-Term Evaluation of Open-Label Pimavanserin Safety and Tolerability in Parkinson's Disease Psychosis

AuthID
P-00S-GYF

Author(s)

Ballard, CG

Kreitzman, DL

Isaacson, S

Liu, IY

Norton, JC

Demos, G

Fernandez, HH

Ilic, TV

Azulay, JP

Ferreira, JJ

Abler, V

Stankovic, S

Group Author(s)

015 Study Grp

Document Type

Article

Year published

2020

Published

in PARKINSONISM & RELATED DISORDERS, ISSN: 1353-8020

Volume: 77, Pages: 100-106 (7)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.parkreldis.2020.06.026

Pubmed: 32712560

Scopus: 2-s2.0-85088394821

Wos: WOS:000578015000023

Source Identifiers

ISSN: 1353-8020

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Long-Term Evaluation of Open-Label Pimavanserin Safety and Tolerability in Parkinson's Disease Psychosis

Useful Links

Get Help

Federated Authentication (Click on the image)

Long-Term Evaluation of Open-Label Pimavanserin Safety and Tolerability in Parkinson's Disease Psychosis

Useful Links

Get Help